Muscarinic receptors in the failing human heart

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 197-202

  Giessler, Christine ^a   Dhein, Stefan ^a   Pönicke, Klaus ^a   Brodde, Otto Erich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adenylyl cyclase; Chronic heart failure; Heart human; Muscarinic M2 receptor; Negative inotropic effect

Indexed keywords

ACETYLCHOLINE; ADENYLATE CYCLASE; CARBACHOL; DOBUTAMINE; FORSKOLIN; ISOPRENALINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; NORADRENALIN; OTENZEPAD; PHOSPHODIESTERASE INHIBITOR; PIRENZEPINE;

CONTROLLED STUDY; HEART; HEART FAILURE; HEART RIGHT ATRIUM; HEART VENTRICLE; HUMAN; HUMAN TISSUE; INOTROPISM; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW;

EID: 0033027754     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00261-7     Document Type: Article

References (70)

1. Anderson F.L., Port J.D., Reid B.B., Larrabee P., Hanson G., Bristow M.R. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with β-adrenergic receptor downregulation. Circulation. 85:1992;46-53.
2. Böhm M. Alterations of β-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol. Cell. Biochem. 147:1995;147-160.
3. iα in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 82:1990;1249-1265.
4. Böhm M., Ungerer M., Erdmann E. Beta adrenoceptors and m-cholinoceptors in myocardium of hearts with coronary artery disease or idiopathic dilated cardiomyopathy removed at cardiac transplantation. Am. J. Cardiol. 66:1990;880-882.
5. 1 adenosine receptors in human myocardium. Am. J. Physiol. 266:1994;H1951-H1958.
6. Böhm M., LaRosee K., Schwinger R.H.G., Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J. Am. Coll. Cardiol. 25:1995;146-153.
7. Bristow M.R. Changes in myocardial and vascular receptors in heart failure. J. Am. Coll. Cardiol. 22(Suppl A):1993;61A-71A.
8. Bristow M.R. Mechanism of action of beta-blocking agents in heart failure. Am. J. Cardiol. 80(11A):1997;26L-40L.
9. 2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol. Rev. 43:1991;203-242.
10. Brodde O.-E. Beta-adrenoceptors in cardiac disease. Pharmacol. Ther. 60:1993;405-430.
11. Brodde O.-E., Michel M.C., Zerkowski H.-R. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc. Res. 30:1995;570-584.
12. Brodde O.-E., Konschak U., Becker K., Rüter F., Poller U., Jakubetz J., Radke J., Zerkowski H.-R. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J. Clin. Invest. 101:1998;471-478.
13. s-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J. Cardiovasc. Pharmacol. 31:1998;585-594.
14. Brown L., Deighton N.M., Bals S., Söhlmann W., Zerkowski H.-R., Michel M.C., Brodde O.-E. Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J. Cardiovasc. Pharmacol. 19:1992;222-232.
15. Caulfield M.P. Muscarinic receptors - characterization, coupling and function. Pharmacol. Ther. 58:1993;319-379.
16. Chidsey C.A., Braunwald E. Sympathetic activity and neurotransmitter depletion in congestive heart failure. Pharmacol. Rev. 18:1966;685-700.
17. Clapham D.E., Neer E.J. G protein βγ subunits. Annu. Rev. Pharmacol. Toxicol. 37:1997;167-203.
18. Cohn J.N. Plasma norepinephrine and mortality. Clin. Cardiol. 18:1995;I9-I12. (Suppl I).
19. Deighton N.M., Motomura S., Borquez D., Zerkowski H.-R., Doetsch N., Brodde O.-E. Muscarinic cholinoceptors in the human heart: demonstration, subclassification, and distribution. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;14-21.
20. Delhaye M., De Smet J.M., Taton G., De Neef P., Camus J.C., Fontaine J., Waelbroeck M., Robberecht P., Christophe J. A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 325:1984;170-175.
21. Du X.Y., Schoemaker R.G., Bos E., Saxena P.R. Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur. J. Pharmacol. 259:1994;173-180.
22. Du X.Y., Schoemaker R.G., Bos E., Saxena P.R. Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium. Eur. J. Pharmacol. 284:1995;119-127.
23. Eckberg D.L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N. Engl. J. Med. 285:1971;877-883.
24. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., Kopin I.J., Goldstein D.S., Esler M.D. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 93:1996;1667-1676.
25. Eschenhagen T. G proteins and the heart. Cell. Biol. Int. 17:1993;723-749.
26. Eschenhagen T., Mende U., Diederich M., Hertle B., Memmesheimer C., Pohl A., Schmitz W., Scholz H., Steinfath M., Böhm M., Michel M.C., Brodde O.-E., Raap A. Chronic treatment with carbachol sensitizes the myocardium to cAMP-induced arrhythmia. Circulation. 93:1996;763-771.
27. Esler M., Kaye D., Lambert G., Esler D., Jennings G. Adrenergic nervous system in heart failure. Am. J. Cardiol. 80(11A):1997;7L-14L.
28. Felder C.C. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J. 9:1995;619-625.
29. Feldman A.M., Bristow M.R. The β-adrenergic pathway in the failing human heart: implications for inotropic therapy. Cardiology. 77:1990;1-32. (Suppl 1).
30. Feldman M.D., Copelas L., Gwathmey J.K., Phillips P., Warren S.E., Schoen F.J., Grossman W., Morgan J.P. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation. 75:1987;331-339.
31. Ferrara N., Davia K., Abete P., Rengo F., Harding S.E. Alterations in β-adrenoceptor mechanisms in the aging heart. Relationship with heart failure. Aging Clin. Exp. Res. 9:1997;391-403.
32. Fu M.L. Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy. Int. J. Cardiol. 54:1996;127-135.
33. Fu L.-X., Liang Q.-M., Waagstein F., Hoebeke J., Sylven C., Jansson E., Sotonyi P., Hjalmarson A. Increase in functional activity rather than in amount of Gi-α in failing human heart with dilated cardiomyopathy. Cardiovasc. Res. 26:1992;950-955.
34. Giessler C., Wangemann T., Zerkowski H.-R., Brodde O.-E. Age-dependent decrease in the negative inotropic effect of carbachol on isolated human right atrium. Eur. J. Pharmacol. 357:1998;199-202.
35. Giles W., Noble S.J. Changes in membrane currents in bullfrog atrium produced by acetylcholine. J. Physiol. (London). 261:1976;103-123.
36. Giraldo E., Martos F., Gomez A., Garcia A., Vigano M.A., Ladinsky H., Sanchez de la Cuesta F. Characterization of muscarinic receptor subtypes in human tissues. Life Sci. 43:1988;1507-1515.
37. Harding S.E., Brown L.A., Wynne D.G., Davies C.H., Poole-Wilson P.A. Mechanisms of β adrenoceptor desensitisation in the failing human heart. Cardiovasc. Res. 28:1994;1451-1460.
38. 2+ channels. Pflüger's Arch. Eur. J. Physiol. 429:1995;531-538.
39. Jakob H., Oelert H., Rupp J., Nawrath H. Functional role of cholinoceptors and purinoceptors in human isolated atrial and ventricular heart muscle. Br. J. Pharmacol. 97:1989;1199-1208.
40. Koglin J., Böhm M., Von Scheidt W., Stäblein A., Erdmann E. Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in vivo. J. Am. Coll. Cardiol. 23:1994;678-683.
41. + channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation. 90:1994;2213-2224.
42. Koumi S., Sato R., Nagasawa K., Hayakawa H. Activation of inwardly rectifying potassium channels by muscarinic receptor-linked G protein in isolated human ventricular myocytes. J. Membr. Biol. 157:1997;71-81.
43. Landzberg J.S., Parker J.D., Gauthier D.F., Colucci W.S. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation. 89:1994;164-168.
44. La Rovere M.T., Mortara A., Pantaleo P., Maestri R., Cobelli F., Tavazzi L. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation. 90:1994;838-843.
45. Le Guludec D., Cohen-Solal A., Delforge J., Delahaye N., Syrota A., Merlet P. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy. An in vivo PET study. Circulation. 96:1997;3416-3422.
46. 2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J. Biol. Chem. 272:1997;12989-12993.
47. Levy M.N. Sympathetic-parasympathetic interactions in the heart. Circ. Res. 29:1971;437-445.
48. Mann D.L., Kent R.L., Parsons B., Copper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:1992;790-804.
49. Mertens M.J.F., Batink H.D., Mathy M.-J., Pfaffendorf M., Van Zwieten P.A. Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy. J. Auton. Pharmacol. 15:1995;465-474.
50. Mery P.-F., Abi-Gerges N., Vandecasteele G., Jurevicius J., Eschenhagen T., Fischmeister R. Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes. Life Sci. 60:1997;1113-1120.
51. Meyer E.C., De Sommers K. Possible mechanisms of anti-cholinergic drug-induced bradycardia. Eur. J. Clin. Pharmacol. 35:1988;503-506.
52. 2-muscarinic receptors in the human right atrium. Br. J. Pharmacol. 101:1990;363-369.
53. Newton G.E., Parker A.B., Landzberg J.S., Colucci W.S., Parker J.D. Muscarinic receptor modulation of basal and β-adrenergic stimulated function of the failing human left ventricle. J. Clin. Invest. 98:1996;2756-2763.
54. 2-cholinoceptor occupancy. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;207-210.
55. Poller U., Nedelka G., Radke J., Pönicke K., Brodde O.-E. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J. Am. Coll. Cardiol. 29:1997;187-193.
56. Pönicke K., Vogelsang M., Heinroth M., Becker K., Zolk O., Böhm M., Zerkowski H.-R., Brodde O.-E. Endothelin receptors in the failing and nonfailing human heart. Circulation. 97:1998;744-751.
57. Porter T.R., Eckberg D.L., Fritsch J.M., Rea R.F., Beightol L.A., Schmedtje J.F. Jr., Mohanty P.K. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J. Clin. Invest. 85:1990;1362-1371.
58. Rundqvist B., Elam M., Bergmann-Sverrisdottir Y., Eisenhofer G., Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation. 95:1997;169-175.
59. Schmitz W., Boknik P., Linck B., Müller F.U. Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure. Mol. Cell. Biochem. 157:1996;251-258.
60. Schulte B., Volz-Zang C., Mutschler E., Horne C., Palm D., Wellstein A., Pitschner H.F. AF-DX 116, a cardioselective muscarinic antagonist in humans: pharmacodynamic and pharmacokinetic properties. Clin. Pharmacol. Ther. 50:1991;372-378.
61. Sharma V.K., Colecraft H.M., Rubin L.E., Sheu S.-S. Does mammalian heart contain only the M2 muscarinic receptor subtype? Life Sci. 60:1997;1023-1029.
62. Strasser R.H., Nuchter I., Rauch B., Marquetant R., Seitz H. Changes in cardiac signal transduction systems in chronic ethanol treatment preceding the development of alcoholic cardiomyopathy. Herz. 21:1996;232-240.
63. 1 adenosine receptors and m-cholinoceptors in human myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;577-585.
64. Vatner D.E., Lee D.L., Schwarz K.R., Longabaugh J.P., Fujii A.M., Vatner S.F., Homcy C.J. Impaired cardiac muscarinic receptor function in dogs with heart failure. J. Clin. Invest. 81:1988;1836-1842.
65. i during pacing-induced heart failure. Circulation. 94:1996;102-107.
66. Von Scheidt W., Böhm M., Stäblein A., Autenrieth G., Erdmann E. Antiadrenergic effect of m-cholinoceptor stimulation on human ventricular contractility in vivo. Am. J. Physiol. 263:1992;H1927-H1931.
67. 2-cholinoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;19-27.
68. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit. Rev. Neurobiol. 10:1996;69-99.
69. 2-muscarinic receptors increase in canine pacing-overdrive model of heart failure. Can. J. Cardiol. 12:1996;71-76.
70. Yamada M., Inanobe A., Kurachi Y. G protein regulation of potassium ion channels. Pharmacol. Rev. 50:1998;723-760.